Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer
暂无分享,去创建一个
[1] Jiang Chang,et al. Aberrant RNA splicing is a primary link between genetic variation and pancreatic cancer risk. , 2022, Cancer Research.
[2] C. Ghigna,et al. A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis , 2021, Nature Communications.
[3] N. Yin,et al. Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis , 2021, Journal of Cancer.
[4] Xiao Jiang,et al. Long non-coding RNA MIR4713HG aggravates malignant behaviors in oral tongue squamous cell carcinoma via binding with microRNA let-7c-5p , 2021, International Journal of Molecular Medicine.
[5] I. Endo,et al. Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer , 2021, Cells.
[6] G. Rätsch,et al. Identification of HIF-dependent alternative splicing in gastrointestinal cancers and characterization of a long, coding isoform of SLC35A3. , 2021, Genomics.
[7] Jia Bi,et al. Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer , 2020, Journal of Cancer.
[8] J. Valle,et al. Pancreatic cancer , 2020, The Lancet.
[9] J. Mayerle,et al. Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer , 2020, Cancers.
[10] Bo Chen,et al. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma , 2020, Aging.
[11] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[12] T. Donahue,et al. Pancreatic Cancer. , 2019, JAMA.
[13] Weifeng Hong,et al. Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer , 2019, Front. Oncol..
[14] Yuanchi Weng,et al. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway , 2019, Cancer biology & therapy.
[15] Chonghui Cheng,et al. CD44 splice isoform switching determines breast cancer stem cell state , 2019, Genes & development.
[16] S. Gong,et al. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma , 2019, EBioMedicine.
[17] P. Vigneri,et al. Insulin Receptor Isoforms in Cancer , 2018, International journal of molecular sciences.
[18] N. Lee,et al. Aberrant RNA Splicing in Cancer and Drug Resistance , 2018, Cancers.
[19] Steven J. M. Jones,et al. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients , 2018, Cancer cell.
[20] Adam Godzik,et al. The Functional Impact of Alternative Splicing in Cancer. , 2017, Cell reports.
[21] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[22] Qian Wang,et al. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer , 2017, Molecular Cancer.
[23] Gloria M. Sheynkman,et al. Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing , 2016, Cell.
[24] Jaime Rodriguez-Canales,et al. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition , 2015, Clinical Cancer Research.
[25] Mark Rosenzweig,et al. Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. , 2015, Cancer discovery.
[26] K. Lillemoe,et al. Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a “True” R0 Resection? , 2013, Annals of surgery.
[27] Michael Peyton,et al. An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.
[28] C. Rinker-Schaeffer,et al. Metastasis-suppressor genes: a review and perspective on an emerging field. , 2000, Journal of the National Cancer Institute.
[29] Yi Pan,et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. , 2020, American journal of cancer research.